Kuros Biosciences announced the appointment of I.V. Hall as Chief Operating Officer, effective June 1, 2026. This shift aims to enhance the company's operational and R&D leadership as it enters its next growth phase.
Who to call at Kuros Biosciences, and when
A new leader at Kuros Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Kuros Biosciences raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Kuros Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kuros Biosciences. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Kuros Biosciences
Location
25 Wagistrasse
Zurich, Switzerland
About
Kuros Biosciences is a leader in innovative biologic technologies. The company specializes in developing solutions for minimally invasive surgical procedures, focusing on bone graft delivery systems. Their mission is to empower surgeons with innovative products that enhance surgical outcomes.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kuros Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ZurichManufacturingBiotechnologyHealth CareMedical Devicemedical devices